Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?

被引：11
|
作者：
Zuin, Marco [1 ,2 ]
Rigatelli, Gianluca [3 ]
Del Favero, Giuseppe [4 ]
Picariello, Claudio [1 ]
Meggiato, Tamara [4 ]
Conte, Luca [1 ]
Faggian, Giuseppe [5 ]
Zuliani, Giovanni [2 ]
Roncon, Loris [1 ]
机构：
[1] Rovigo Gen Hosp, Dept Cardiol, Rovigo, Italy
[2] Univ Ferrara, Sect Internal & Cardiopulm Med, Dept Med Sci, Ferrara, Italy
[3] Rovigo Gen Hosp, Dept Cardiovasc Diag & Endoluminal Intervent, Rovigo, Italy
[4] Rovigo Gen Hosp, Dept Gastroenterol, Rovigo, Italy
[5] Univ Verona, Dept Cardiac Surg, Verona, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 223卷
关键词：
Coronary artery disease; Helicobacter pylori; Cardiovascular prevention; METAANALYSIS;
D O I：
10.1016/j.ijcard.2016.08.320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [21] Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy
    Lou Jin-gan
    Chen Jie
    Huang Xiao-lei
    Zhao Zheng-yan
    CHINESE MEDICAL JOURNAL, 2007, 120 (10) : 929 - 931
  • [22] Eradication therapy for Helicobacter pylori infection: Review of world trends
    Maev, I. V.
    Kucheryavyi, Yu A.
    Andreev, D. N.
    Barkalova, E. V.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (03) : 94 - 99
  • [23] Helicobacter pylori infection and the risk for cardiovascular disease
    Kountouras, Jannis
    Polyzos, Stergios A.
    Deretzi, Georgia
    Katsinelos, Panagiotis
    Kyriakou, Panagiota
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (06) : E146 - E147
  • [24] Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy
    LOU Jin-gan CHEN Jie HUANG Xiao-lei ZHAO Zheng-yan Department of Gastroenterology
    中华医学杂志(英文版), 2007, (10) : 929 - 931
  • [25] Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection
    Yurenev, G. L.
    Partzvania-Vinogradova, E. V.
    Andreev, D. N.
    Dicheva, D. T.
    Maiev, I. V.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (08) : 33 - 39
  • [26] Helicobacter pylori infection is an infectious disease and the empiric therapy paradigm should be changed
    Li, Hong
    Yang, Tiankuo
    Tang, Hong
    Tang, Xiaoqiong
    Shen, Yalin
    Benghezal, Mohammed
    Tay, Alfred
    Marshall, Barry
    PRECISION CLINICAL MEDICINE, 2019, 2 (02) : 77 - 80
  • [27] Time for Routine Helicobacter pylori Screening in Coronary Artery Disease?
    Hofmann, Robin
    Back, Magnus
    CIRCULATION, 2023, 147 (23) : 1731 - 1733
  • [28] Helicobacter pylori: Does it add to risk of coronary artery disease
    Sharma, Vishal
    Aggarwal, Amitesh
    WORLD JOURNAL OF CARDIOLOGY, 2015, 7 (01): : 19 - 25
  • [29] Helicobacter pylori infection and risk of cardiovascular disease
    Sun, Lichang
    Zheng, Haoxiao
    Qiu, Min
    Hao, Shali
    Liu, Xiong
    Zhu, Xiaolin
    Cai, Xiaoyan
    Huang, Yuli
    HELICOBACTER, 2023, 28 (03)
  • [30] Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice
    Andreev, D. N.
    Dicheva, D. T.
    Maev, I. V.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (02) : 84 - 90
12345